OQROGet OQRO Pro
Insider trade

Encompass Health (EHC)CEO sold ~$678K

Mark J Tarr, CEO at Encompass Health, sold ~$678K of Encompass Health shares.

~$678K
Approx. value · 6,057 sh @ $111.89
465K
Holds after · shares reported
Traded
Feb 11, 2026
Filed
Feb 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 5, 2025Federal contract · $17K obligatedDepartment of Justice awarded Encompass Health Corp: $17K obligated to date
  2. Jan 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 30, 2026, the Board of Directors (the “Board”) of Encompass Health Corporation (the “Company”), upon the recommendation of its Nominating/Corporate Governance Committee, elected Cain A. Hayes as director.”
  3. Feb 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  4. Feb 10, 2026InsiderOfficer sold ~$302K of EHC shares in the open market
  5. Feb 11, 2026 · this disclosureInsiderCEO sold ~$678K of EHC shares in the open market

What came next

  1. Feb 11, 2026Insider · 1 personInsiders: 6 sales (~$16.1M)
  2. Feb 19, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 30, 2026, the Board unanimously approved the appointment of Cain A. Hayes as director. On February 19, 2026, the Board appointed Mr. Hayes to its Compensation and Human Capital Committee and its Compliance and Quality of Care Committee.”
  3. Mar 9, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
  4. Mar 9, 2026Insider · First sale since 2016Officer sold ~$1.28M of EHC shares in the open market
  5. Apr 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  6. May 11, 2026InsiderOfficer sold ~$71K of EHC shares in the open market
  7. May 14, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  8. May 15, 2026Insider · 1 personInsiders: 2 sales (~$3.0M)
  9. May 29, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Encompass Health

For Encompass Health, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EHC page.

Other recent filings by Mark J Tarr, President & CEO

The full history of Mark J Tarr, President & CEO is on the profile page.

How this filing works

Other disclosures at Encompass Health

Everything OQRO holds on this company is on its EHC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data